⌘K

Home/Filings/4/0001062993-24-016035

4//SEC Filing

BAMFORD PASCAL 4

Accession 0001062993-24-016035

CIK 0001711933other

View on SEC.gov Company Profile

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 9:41 PM ET

Size

4.9 KB

Accession

0001062993-24-016035

Insider Transaction Report

Form 4

Period: 2024-08-29

Akoya Biosciences, Inc.AKYA

Chief Clinical Officer

Transactions

Award
Common Stock
2024-08-29+40,000→ 122,758 total

Footnotes (2)

[F1]The restricted stock units shall vest in full on the second anniversary of the first day of the month subsequent to the date of grant.
[F2]Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Akoya Biosciences, Inc.

CIK 0001711933

Entity typeother

Related Parties

1

filerCIK 0002035474

Filing Metadata

Form type: 4
Filed: Sep 2, 8:00 PM ET
Accepted: Sep 3, 9:41 PM ET
Size: 4.9 KB

View on SEC.gov